What MNCs Can Learn from Generics Companies

Pharmaceutical Executive

In the last three decades, MNCs have contributed greatly to the transfer of knowledge to generic companies in areas such as technology,

In the last three decades, MNCs have contributed greatly to the transfer of knowledge to generic companies in areas such as technology, marketing know-how, working methods, management techniques, R&D, and branding. However, now is the time that MNCs can also learn significantly from generic companies amid the changing global industry landscape. This evolution has enabled generic companies to outpace MNCs’ performance in most emerging markets, including Asia.

In this month’s Pharmaceutical Executive, Nadeem Rehmat lists 13 important lessons that pharma MNCs can learn from generic companies when planning and designing their strategies in emerging markets in Asia and other regions.

Read the full article here.